Concepedia
Statistics
Publications
5
Citations
229
H-Index
Active since
1999
Affiliations
Novartis (United States)(Current)
Mayo Clinic in Arizona
IBM (United States)
Quincy Chau is an author at Novartis (United States) specializing in oncology, chemotherapy, and medicine.
Publications per year
1999–2020
Artificial Intelligence Tool for Optimizing Eligibility Screening for Clinical Trials in a Large Community Cancer Center
J. Thaddeus Beck, Melissa Rammage, Gretchen Purcell Jackson et al. · JCO Clinical Cancer Informatics · 2020 · 131 citations
Computing, Computer Science, Oncology +17
Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant
Quincy Chau, David J. Stewart · Cancer Chemotherapy and Pharmacology · 1999 · 34 citations · Full text
Medicine, Cell Biology, Oncology +12
Clinical performance pilot using cognitive computing for clinical trial matching at Mayo Clinic.
J. Helgeson, Melissa Rammage, Alexandra Urman et al. · Journal of Clinical Oncology · 2018 · 30 citations
Computing, Health Informatics, Oncology +13
Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study.
Patrick B. Johnston, Lauren Pinter‐Brown, Jaqueline Willemann Rogerio et al. · Blood · 2012 · 19 citations
Medicine, Oncology, Pharmacotherapy +10
PILLAR-1: Preliminary Results of a Phase II Study of mTOR Inhibitor Everolimus In Patients with Mantle Cell Lymphoma (MCL) Who Are Refractory or Intolerant to Bortezomib
Owen A. O’Connor, Leslie Popplewell, Jane N. Winter et al. · Blood · 2010 · 15 citations
Medicine, Oncology, Pharmacology +17
1–5 of 5